Oops! You must enter a search term greater than 3 characters.

Profile moreless )

PO Box 13067
% Don Collins Pres

Research Triangle Park
North Carolina 27709
USA

Please to add this organization to your favorites.

Add to my favorites Added to favorites!

Programs: ISAF’S CURRENT PROGRAMMATIC GOAL IS UNITED STATES FOOD & DRUG ADMINISTRATION (FDA) APPROVAL FOR MARKETING AND CLIENT USAGE OF THE QUINACRINE PELLET SYSTEM OF PERMANENT CONTRACEPTION FOR WOMEN (QS).  ISAF RESEARCHES, PUBLISHES AND EDUCATES ABOUT QS THROUGH A CLINICAL OUTREACH PROGRAM, PEER REVIEWED JOURNAL ARTICLES, AND A MEDICAL CONFERENCES PRESENCE.  IN 2001, ISAF COMPLETED AN FDA-APPROVED PHASE I TRIAL OF QS CONDUCTED BY DR. JACK LIPPES OF STATE UNIVERSITY OF NEW YORK IN BUFFALO. IN 2006, ISAF OBTAINED FDA APPROVAL TO COMMENCE A PHASE 3 CLINICAL TRIAL OF QS IN THE UNITED STATES, IN WHICH 40 PHYSICIAN INVESTIGATORS AND THEIR CLINICAL STAFF FROM U.S. MEDICAL SCHOOLS AND CLINICS HAVE CHOSEN TO PARTICIPATE. FDA PLACED A CLINICAL HOLD ON THIS PHASE 3 TRIAL IN 2007 AND INVITED ISAF TO SUBMIT NEW INFORMATION ON THE SAFETY OF QS IN HUMANS. AFTER THIS NEW DATA IS SUBMITTED TO FDA, EXPECTED IN MID-2010, ISAF ANTICIPATES RESUMPTION OF THE CLINICAL TRIAL.

Mission:
TO ENCOURAGE WOMEN’S REPRODUCTIVE HEALTH, RIGHTS AND EMPOWERMENT THROUGH RESEARCH AND EDUCATION, PARTICULARLY BY FACILITATING THE USE OF SAFE, INEXPENSIVE, NON-COERCIVE FAMILY PLANNING METHODS, SPECIFICALLY THE QUINACRINE PELLET METHOD OF NONSURGICAL PERMANENT FEMALE CONTRACEPTION – QS.
Results:

Invite reviews

Invite friends and colleagues to share their experiences with this nonprofit

Photos & Video

Are you the Nonprofit? Your photos and videos would look great here!

Promote This Nonprofit

Great Nonprofits badges allow you to raise awareness of your favorite organizations on your own web sites. for text link or graphic badge.

Get badge
By registering you agree to the site's Terms and Conditions.